Citadel Advisors’s Gyre Therapeutics GYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,198
Closed -$23.1K 6205
2023
Q3
$23.1K Buy
+3,198
New +$23.1K ﹤0.01% 5283
2023
Q2
Sell
-1,057
Closed -$3.28K 6064
2023
Q1
$3.28K Sell
1,057
-40,505
-97% -$126K ﹤0.01% 5646
2022
Q4
$164K Buy
41,562
+33,402
+409% +$132K ﹤0.01% 4796
2022
Q3
$31K Sell
8,160
-1,957
-19% -$7.44K ﹤0.01% 5441
2022
Q2
$135K Buy
+10,117
New +$135K ﹤0.01% 5163
2022
Q1
Sell
-4,202
Closed -$29K 6662
2021
Q4
$29K Sell
4,202
-4,519
-52% -$31.2K ﹤0.01% 6270
2021
Q3
$268K Buy
+8,721
New +$268K ﹤0.01% 5120
2021
Q2
Hold
0
6668
2021
Q1
Sell
-5,909
Closed -$280K 6472
2020
Q4
$280K Buy
5,909
+1,786
+43% +$84.6K ﹤0.01% 4282
2020
Q3
$133K Sell
4,123
-51,059
-93% -$1.65M ﹤0.01% 4189
2020
Q2
$2.43M Sell
55,182
-27,597
-33% -$1.22M ﹤0.01% 2075
2020
Q1
$2.71M Buy
82,779
+32,755
+65% +$1.07M ﹤0.01% 1953
2019
Q4
$2.56M Buy
50,024
+10,582
+27% +$540K ﹤0.01% 2140
2019
Q3
$1.45M Buy
39,442
+32,167
+442% +$1.18M ﹤0.01% 2622
2019
Q2
$402K Buy
7,275
+506
+7% +$28K ﹤0.01% 3681
2019
Q1
$412K Sell
6,769
-3,168
-32% -$193K ﹤0.01% 3507
2018
Q4
$588K Buy
9,937
+4,095
+70% +$242K ﹤0.01% 3173
2018
Q3
$472K Buy
5,842
+3,919
+204% +$317K ﹤0.01% 3197
2018
Q2
$168K Buy
+1,923
New +$168K ﹤0.01% 3735
2018
Q1
Hold
0
4145
2017
Q1
Sell
-212
Closed -$16K 3860
2016
Q4
$16K Buy
212
+49
+30% +$3.7K ﹤0.01% 3484
2016
Q3
$22K Buy
+163
New +$22K ﹤0.01% 3401
2015
Q2
Sell
-17
Closed -$41K 3913
2015
Q1
$41K Sell
17
-4
-19% -$9.65K ﹤0.01% 3417
2014
Q4
$44K Buy
21
+11
+110% +$23K ﹤0.01% 3422
2014
Q3
$20K Buy
10
+6
+150% +$12K ﹤0.01% 3294
2014
Q2
$15K Buy
+4
New +$15K ﹤0.01% 3331
2014
Q1
Sell
-4
Closed -$12K 3650
2013
Q4
$12K Hold
4
﹤0.01% 2985
2013
Q3
$15K Sell
4
-6
-60% -$22.5K ﹤0.01% 2820
2013
Q2
$35K Buy
+10
New +$35K ﹤0.01% 2581